Literature DB >> 31784758

miR-181a-2* expression is different amongst carcinomas from the colorectal serrated route.

Alexandra Kondelova1,2, Begoña Alburquerque-González3, Petra Vychytilova-Faltejskova2, José García-Solano1,3,4, Vladimir Prochazka5, Zdenek Kala5, Fernando Pérez6, Ondrej Slaby2,7, Pablo Conesa-Zamora3,4,8.   

Abstract

Serrated adenocarcinoma (SAC) and colorectal carcinomas showing histological and molecular features of high-level of microsatellite instability (hmMSI-H) are both end points of the serrated pathway of colorectal carcinogenesis. Despite common features (right-sided location, CpG island methylation phenotype and BRAF mutation) there are no studies comparing the microRNA (miRNA) expression profiles in SACs and hmMSI-H. The microtranscriptome from 12 SACs and 8 hmMSI-H were analysed using Affymetrix GeneChip miRNA 3.0 arrays and differentially enriched functions involving immune response were observed from this comparison. miR-181a-2* was found significantly more expressed in hmMSI-H than in SAC and higher expression of this miRNA in microsatellite unstable colorectal cancer were corroborated by Real-Time PCR in an extended series (61 SAC, 21 hmMSI-H). An analysis of genes possibly regulated by miR-181a-2* was carried out and, amongst these, an inverse correlation of NAMPT with miR-181a-2* expression was observed, whereas, for TRAF1 and SALL1, additional regulation mechanisms involving CpG island methylation were observed. miR-181a-2* is associated with particular histological and molecular features of colorectal carcinomas within the serrated pathological pathway and might play a role in the immune responses of microsatellite instability carcinomas.
© The Author(s) 2019. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 31784758     DOI: 10.1093/mutage/gez039

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  3 in total

Review 1.  What could microRNA expression tell us more about colorectal serrated pathway carcinogenesis?

Authors:  Milena Peruhova; Monika Peshevska-Sekulovska; Boris Krastev; Gabriela Panayotova; Viktoriya Georgieva; Rossitza Konakchieva; Georgi Nikolaev; Tsvetelina Veselinova Velikova
Journal:  World J Gastroenterol       Date:  2020-11-14       Impact factor: 5.742

Review 2.  Biology and Therapeutic Targets of Colorectal Serrated Adenocarcinoma; Clues for a Histologically Based Treatment against an Aggressive Tumor.

Authors:  Begoña Alburquerque-González; Fernando F López-Calderón; María Dolores López-Abellán; Ángel Esteban-Gil; José García-Solano; Pablo Conesa-Zamora
Journal:  Int J Mol Sci       Date:  2020-03-14       Impact factor: 5.923

Review 3.  SALL Proteins; Common and Antagonistic Roles in Cancer.

Authors:  Claudia Álvarez; Aracelly Quiroz; Diego Benítez-Riquelme; Elizabeth Riffo; Ariel F Castro; Roxana Pincheira
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.